Madeleine G. Haff, MD

Assistant Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Madeleine G. Haff, MD, is a physician in the Section of Gastroenterology at Boston Medical Center, and is an Assistant Professor at the Boston University School of Medicine. She serves as the Associate Program Director of the Gastroenterology and Hepatology Fellowship Program.

A graduate of Williams College, Dr. Haff received her MD from the Geisel School of Medicine at Dartmouth where she was the president of the Dartmouth chapter of the Alpha Omega Alpha honor society as well as a member of the Gold Humanism Honor Society. She completed her Internal Medicine Residency at Beth Israel Deaconess Hospital in Boston and her fellowship in Gastroenterology and Hepatology at Boston Medical Center (BMC). She is board certified in Internal Medicine and Gastroenterology. She is a member of American Association for the Study of Liver Diseases and the American College of Gastroenterology.

An attending physician in the section of Gastroenterology and Hepatology, Dr. Haff provides care to both those with general GI disorders as well as liver-specific disorders.

Her research focuses on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), care delivery, and predictive markers of disease. She has been involved and led several projects examining MASLD, cardiovascular risk, and predictors of disease in the Framingham Heart Study. She also serves as co-investigator on several clinical trials on chronic liver diseases.

Publications

  • Published 11/1/2025

    Haff MG, Murabito JM, Vasan RS, Spartano NL, Liu CT, Zhang X, Benjamin EJ, Lewis GD, Long MT. Physical Activity by Accelerometer Inversely Associated With Liver Fibrosis; Cross-Sectional Analysis of a Longitudinal Cohort. Liver Int. 2025 Nov; 45(11):e70380. PMID: 41055309.

    Read at: PubMed

  • Published 10/7/2025

    Ghusn W, Sridharan M, Fromer R, Ozdemir M, Haff MG, Vargas EJ. Endoscopic Bariatric Therapies for Metabolic Dysfunction-Associated Steatotic Liver Disease: Mechanistic Insights and Metabolic Implications. Biomedicines. 2025 Oct 07; 13(10). PMID: 41153720.

    Read at: PubMed

  • Published 5/15/2025

    El-Sabawi B, Tanriverdi K, Gajjar P, Nayor M, Landman JM, Below JE, Haff M, Long M, Ezpeleta M, Freedman JE, Varady K, Shah R, Perry AS. Circulating Proteomics Identifies a Dynamic Profile of Hepatic Steatosis During Metabolic Intervention. J Am Heart Assoc. 2025 May 20; 14(10):e037100. PMID: 40371575.

    Read at: PubMed

  • Published 1/1/2025

    Florea VV, Gajjar P, Huang S, Tang J, Zhao S, Davenport M, Mi MY, Haff M, Zhang X, Miller PE, Vasan RS, Liu CT, Lewis GD, Shah RV, Long MT, Nayor M. Hepatic Steatosis and Fibrosis, Cardiorespiratory Fitness, and Metabolic Mediators in the Community. Liver Int. 2025 Jan; 45(1):e16147. PMID: 39673712.

    Read at: PubMed

  • Published 7/20/2024

    Kumar S, Mohanty A, Mantry P, Schwartz RE, Haff M, Therapondos G, Noureddin M, Dieterich D, Girgrah N, Cohn K, Savanth M, Fuchs M. Deploying a metabolic dysfunction-associated steatohepatitis consensus care pathway: findings from an educational pilot in three health systems. BMC Prim Care. 2024 Jul 20; 25(1):265. PMID: 39033284.

    Read at: PubMed

View All 9 Publications:   View Full Profile in BUMC

Websites

Education

  • Geisel School of Medicine, MD
  • Williams College, BA

View all profiles